Baheal Pharma Group is a health industry group which is driven by scientific and technical innovation. The Group is based on its commercialization capabilities, with a core focus on asset accretion, and with innovative incubation as its characteristics. Its key business include a health brand commercialization platform, investment and incubation for innovative achievements. The Group is dedicated to providing better health products and services for all society, while also providing practical optimization for the medical field.
Beheal consistently endeavors to discover innovations that have clinical applicability at their source, cultivates pharmaceutical health products and services that hold China's independent intellectual property rights, and uses technological innovation to optimize healthcare scenarios.